E-LIB Suche - Ergebnisse für: Vidriales, Belén

1

Incidence, risk factors, and outcomes of second neoplasms i..:

Sobas, Marta ; Knopinska-Posluszny, Wanda ; Piątkowska-Jakubas, Beata...
Annals of Hematology. 103 (2023) 2 - p. 451-461 , 2023

Link: https://doi.org/10.1007/..

2

A phase 3 trial of azacitidine versus a semi‐intensive flud..:

Vives, Susana ; Martínez‐Cuadrón, David ; Bergua Burgues, Juan...
Cancer. 127 (2021) 12 - p. 2003-2014 , 2021

Link: https://doi.org/10.1002/..

3

Long-Term Outcomes After Autologous Versus Allogeneic Stem ..:

Rodríguez-Arbolí, Eduardo ; Martínez-Cuadrón, David ; Rodríguez-Veiga, Rebeca...
Transplantation and Cellular Therapy. 27 (2021) 4 - p. 311.e1-311.e10 , 2021

Link: https://doi.org/10.1016/..

4

DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES I..:

Montesinos, Pau ; Sanz, Miguel Ángel ; Ballesteros, Joan...
Mediterranean Journal of Hematology and Infectious Diseases. 11 (2019) 1 - p. e2019016 , 2019

Link: https://doi.org/10.4084/..

5

Correction to: A phase I–II study of plerixafor in combinat..:

on behalf of the CETLAM and PETHEMA groups ; Martínez-Cuadrón, David ; Boluda, Blanca...
Annals of Hematology. 97 (2018) 5 - p. 923-923 , 2018

Link: https://doi.org/10.1007/..

6

A phase I–II study of plerixafor in combination with fludar..:

on behalf of the CETLAM and PETHEMA groups ; Martínez-Cuadrón, David ; Boluda, Blanca...
Annals of Hematology. 97 (2018) 5 - p. 763-772 , 2018

Link: https://doi.org/10.1007/..

7

Classification and clinical behavior of blastic plasmacytoi..:

Martín-Martín, Lourdes ; López, Antonio ; Vidriales, Belén...
Oncotarget. 6 (2015) 22 - p. 19204-19216 , 2015

Link: https://doi.org/10.18632..

8

Analysis and clinical correlation of infiltrating cytotoxic..:

Alonso-Alvarez, Sara ; Vidriales, Belen ; Caballero, Maria Dolores...
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. S39 , 2015

Link: https://doi.org/10.1016/..

9

Role of minimal residual disease and chimerism after reduce..:

Bernal, Teresa ; Diez-Campelo, María ; Godoy, Vicky...
Leukemia Research. 38 (2014) 5 - p. 551-556 , 2014

Link: https://doi.org/10.1016/..

10

Pharmacological Profiles of Acute Myeloid Leukemia Treatmen..:

Bennett, Teresa A. ; Montesinos, Pau ; Moscardo, Federico...
Clinical Lymphoma Myeloma and Leukemia. 14 (2014) 4 - p. 305-318 , 2014

Link: https://doi.org/10.1016/..

11

Phase II trial to assess the safety and efficacy of clofara..:

Martínez-Cuadrón, David ; Montesinos, Pau ; Oriol, Albert...
Annals of Hematology. 93 (2013) 1 - p. 43-46 , 2013

Link: https://doi.org/10.1007/..

12

Differential Diagnosis of IgM MGUS and WM According to B-Ly..:

Ocio, Enrique M. ; Carpio, Daniel del ; Caballero, Álvaro...
Clinical Lymphoma Myeloma and Leukemia. 11 (2011) 1 - p. 93-95 , 2011

Link: https://doi.org/10.3816/..

13

Minimal residual disease monitoring after allogeneic transp..:

Díez‐Campelo, María ; Pérez‐Simón, José Antonio ; Pérez, Jose...
American Journal of Hematology. 84 (2009) 3 - p. 149-152 , 2009

Link: https://doi.org/10.1002/..

14

Detailed immunophenotypic characterization of different maj..:

Hernández‐Campo, Pilar M. ; Almeida, Julia ; Acevedo, María J....
Transfusion. 48 (2008) 7 - p. 1403-1414 , 2008

Link: https://doi.org/10.1111/..

15

Cell Cycle Analysis of Waldenström's Macroglobulinemia:

Ocio, Enrique M. ; Mateo, Gema ; Vidriales, Belén...
Clinical Lymphoma. 5 (2005) 4 - p. 250-252 , 2005

Link: https://doi.org/10.3816/..